Survival of End Stage Renal Failure Patients with Cancer

Slides:



Advertisements
Similar presentations
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Advertisements

This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Living Donor Kidney Transplant. What does the evidence say about outcome ? Professor Peter J Conlon.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Recurrence of Malignancy after Transplantation ANZDATA - Australian and New Zealand Dialysis and Transplant Registry NSW Cancer Council.
©2012 Australian Indigenous HealthInfoNet1 Overview of Australian Indigenous health status 2011 Key facts.
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
LUNG TRANSPLANTATION Adult Recipients 2014 JHLT Oct; 33(10):
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Section 1: CKD Epidemiology
The Changing Face of Cancer in Iowa
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
What does the data tell us? Colorectal CANCER IN NEVADA
ANZDATA session ANZSN-ASM 2017
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Analysis of Non-cutaneous Cancer after Lung Transplantation
Overview of Australian Aboriginal and Torres Strait Islander health status 2015 Key facts.
Renal Transplant Audit (including liver+kidney) 2010 David Milford Department of Nephrology Birmingham Children’s Hospital.
April 18 Intro to survival analysis Le 11.1 – 11.2
The Increased Mortality and the Medicare Disability Eligibility Status of the HCV Population in the US Gabriela Dieguez1, Bruce Pyenson1, Steven E Marx2,
Ovarian Cancer (C56): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.
Patient populations by study group figure 10
John P. Dickerson, Tuomas Sandholm In AAAI, 2015
Cancer of the Body of the Uterus (C54):
Mortality rates in incident ESRD patients figure 9
Volume 2: End-Stage Renal Disease
UK Renal Registry 15th Annual Report
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
UK Renal Registry 18th Annual Report
Number of Grafts Performed by Country
Testicular Cancer (C62):
Cervical Cancer (C53): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.
C. Chalklin, C. Colmont, A. Zaidi, J. Warden-Smith, E. Ablorsu
Breast Cancer (C50): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation provided.
Bowel Cancer (C18-C20): Five-Year Relative Survival (%) by Stage, Adults Aged 15-99, Former Anglia Cancer Network Please include the citation.
Recently Diagnosed vs Chronic HF Associated with Better Outcomes
Kidney Transplant The Preferred Treatment for Most Patients with Kidney Failure Information for Patients July 2018.
Adjusted relative mortality risk
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
ANZDATA Registry Annual Report 2013
Results - Proportion of people dying at home
The Changing Face of Cancer in Iowa
MEASURING HEALTH STATUS
Results - Proportion of people dying at home
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
UK Renal Registry 13th Annual Report
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
William S. Asch, Margaret J. Bia  Advances in Chronic Kidney Disease 
National Cancer Statistics in Korea, 2015
Cause Specific Death Rates for All Dialysis Patients
Survival advantage in Asian American end-stage renal disease patients1
Volume 68, Issue 5, Pages (November 2005)
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
Volume 71, Issue 12, Pages (June 2007)
The Burden of Cancer in Nova Scotia an evaluation of loss in expectation of life Ron Dewar Registry and Analytics Presented to the joint NAACCR.
Dialysis outcomes in Australia & New Zealand
Number of Donors in Australia
Figure 3.1 Death Rates by States All Dialysis Patients
CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES
Presentation transcript:

Survival of End Stage Renal Failure Patients with Cancer Angela Webster Centre for Kidney Research, The Children’s Hospital at Westmead Department of Renal Medicine, Westmead Hospital, NSW School of Public Health, University of Sydney

Cumulative risk of diagnosis of cancer after start of dialysis Patients at Risk (30,892) Orientate you to this graph We can see that for a patient surving 5 years on dialysis just under 10% will be diagnosed with a non skin cancer (green) this risk rises steadily with time

Cumulative risk of diagnosis of cancer post transplantation Patients at Risk (8,881) For transplant recipients ( cadaveric donor) risk is somewhat higher, with

Australia 2002 6812 people on dialysis 1079 dialysis deaths 63 (5.8%) deaths attributed to cancer Greater number, but smaller proportion of patients on dialysis died of their cancer smaller number, but greater proportion of patients with transplant diesd of their cancer.

Australia 2002 6812 people on dialysis 1079 dialysis deaths 63 (5.8%) deaths attributed to cancer 922 (13.5%) alive with a diagnosis of cancer Greater number, but smaller proportion of patients on dialysis died of their cancer smaller number, but greater proportion of patients with transplant diesd of their cancer.

Australia 2002 6812 people on dialysis 1079 dialysis deaths 63 (5.8%) deaths attributed to cancer 922 (13.5%) alive with a diagnosis of cancer 5466 people with a functioning transplant 149 deaths 37 (25%) deaths attributed to cancer Greater number, but smaller proportion of patients on dialysis died of their cancer smaller number, but greater proportion of patients with transplant diesd of their cancer.

Australia 2002 6812 people on dialysis 1079 dialysis deaths 63 (5.8%) deaths attributed to cancer 922 (13.5%) alive with a diagnosis of cancer 5466 people with a functioning transplant 149 deaths 37 (25%) deaths attributed to cancer 735 (13.4%) alive with a diagnosis of cancer Greater number, but smaller proportion of patients on dialysis died of their cancer smaller number, but greater proportion of patients with transplant diesd of their cancer.

Common cancers 1963-2002

Common cancers 1963-2002

Common cancers 1963-2002

Common cancers 1963-2002

Common non-skin cancers Relative and absolute risks Analysis of survival Attributed cause of death

All non - skin cancers  age matched SA population  per 1000

Survival: all cancers Pre-ESRF Post transplant Dialysis ORIENTATE mean age RR Survival For all cancer types survival is worse for patients on dialysis compared to those transplanted Pts diagnosed pre ESRF are a highly selected population. As you would expect of long term survivors, their death rate is constant with time , total N 1549 mortality steady at 4% per annum For both dialysis and pos trnasplant populations the grwtrest attrition rates are in the first 2 years The overall relative risk of a cancer in dialysis population compared to a normal age matched south australian population is 1.4. median mortalityfor the dialysis population is 0.86/year +just over 10 months The overall relative risk of a cancer in dialysis population compared to a normal age matched south australian population is 3.1 post trnasplant population = 2.23 yrs, 2 years 3 months

Cause of death of cancer patients Cause of death of patients with a cancer diagnosis listed for only 70% patients…… currently exploring the reasons…….. Greater proportion of dialysis patients have missing causes of death. More likely to be listed as causing death for tx pts. Cardiac +social less likely vascular and other relatively steady

Colon cancer  age matched SA population  per 1000

Survival: colon cancer Pre-ESRF Post transplant Dialysis Some cancers seem to have uniformly poor survival numbers pre esrf 150 on dialysis 72 post Tx 93

Attributed cause of death

Attributed cause of death

Lung cancer  age matched SA population  per 1000

Survival: lung cancer Pre-ESRF Dialysis Post transplant Pre esrf 23 on dialysis 155 post tx 103 Post transplant

Attributed cause of death

Attributed cause of death

Melanoma  age matched SA population  per 1000

Survival: melanoma Pre-ESRF Post transplant Dialysis Pre esrf 99 on dialysis 64 post tx 175 mortality in the first year equal, and then we see separation

Attributed cause of death

Attributed cause of death

Conclusions Common cancers in the general population are more common in the ESRF population For any cancer type, survival is worse for patients diagnosed whilst on dialysis than post transplantation Deaths from cancer are proportionally far greater post transplantation

Future directions Re-analysis of survival adjusting for confounders age duration of ESRF Comparison with general population Linkage of databases